Michael C. Dugan

1.1k total citations
30 papers, 879 citations indexed

About

Michael C. Dugan is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael C. Dugan has authored 30 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael C. Dugan's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Brain Metastases and Treatment (4 papers). Michael C. Dugan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Brain Metastases and Treatment (4 papers). Michael C. Dugan collaborates with scholars based in United States, Australia and Russia. Michael C. Dugan's co-authors include Vainutis K. Vaitkevicius, Sanaa T. Dergham, Fazlul H. Sarkar, John D. Crissman, Wei Du, Michael Park, Mark Yim, Jimmy Sastra, Chris Taylor and Yong Q. Chen and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael C. Dugan

30 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. Dugan United States 16 494 380 130 108 93 30 879
Aeree Kim South Korea 20 444 0.9× 548 1.4× 264 2.0× 72 0.7× 43 0.5× 42 1.0k
Paul G. O’Reilly United Kingdom 19 286 0.6× 364 1.0× 150 1.2× 70 0.6× 40 0.4× 51 1.0k
Raphael Pelossof United States 12 290 0.6× 261 0.7× 98 0.8× 153 1.4× 37 0.4× 20 752
Fredrik Erlandsson Sweden 18 255 0.5× 759 2.0× 96 0.7× 117 1.1× 155 1.7× 36 1.5k
Yuze Wu China 13 585 1.2× 396 1.0× 164 1.3× 38 0.4× 27 0.3× 33 1.3k
Tsutomu Iwasa Japan 23 765 1.5× 455 1.2× 187 1.4× 175 1.6× 96 1.0× 82 1.5k
Xin Song China 15 403 0.8× 428 1.1× 167 1.3× 141 1.3× 46 0.5× 57 891
Omar Khan United States 14 1.4k 2.7× 487 1.3× 134 1.0× 54 0.5× 105 1.1× 22 2.4k
Dapeng Hao China 21 297 0.6× 1.1k 3.0× 846 6.5× 74 0.7× 102 1.1× 71 1.9k
Vidya Kamath United States 9 316 0.6× 371 1.0× 194 1.5× 52 0.5× 50 0.5× 23 843

Countries citing papers authored by Michael C. Dugan

Since Specialization
Citations

This map shows the geographic impact of Michael C. Dugan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Dugan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Dugan more than expected).

Fields of papers citing papers by Michael C. Dugan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Dugan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Dugan. The network helps show where Michael C. Dugan may publish in the future.

Co-authorship network of co-authors of Michael C. Dugan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Dugan. A scholar is included among the top collaborators of Michael C. Dugan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Dugan. Michael C. Dugan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blouw, Barbara, Tony J. Pircher, Julie Ann Mayer, et al.. (2024). A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal Metastases. Archives of Pathology & Laboratory Medicine. 149(3). 242–252. 1 indexed citations
2.
Okafor, C. Denise, Richard J. Whitby, Devrishi Goswami, et al.. (2016). Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists. Journal of Biological Chemistry. 291(49). 25281–25291. 24 indexed citations
3.
Anderson, Steven M., Kenneth J. Bloom, Josef Rueschoff, et al.. (2012). Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection of BRAF V600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma. Archives of Pathology & Laboratory Medicine. 136(11). 1385–1391. 113 indexed citations
4.
Hipp, Jason, Jerome Cheng, Stephanie Daignault, et al.. (2011). Automated area calculation of histopathologic features using SIVQ.. SHILAP Revista de lepidopterología. 34(5). 265–75. 9 indexed citations
5.
Yim, Mark, et al.. (2007). Towards robotic self-reassembly after explosion. 2767–2772. 73 indexed citations
6.
Pernick, Nat, Fazlul H. Sarkar, Philip A. Philip, et al.. (2003). Clinicopathologic Analysis of Pancreatic Adenocarcinoma in African Americans and Caucasians. Pancreas. 26(1). 28–32. 43 indexed citations
7.
Vaishampayan, Ulka N., et al.. (2001). Blastic mantle cell lymphoma associated with Burkitt‐type translocation and hypodiploidy. British Journal of Haematology. 115(1). 66–68. 23 indexed citations
8.
Adsay, Volkan, Sanaa T. Dergham, Michael C. Dugan, et al.. (1999). Utility of Fluorescence In Situ Hybridization in Pancreatic Ductal Adenocarcinoma. Pancreas. 18(2). 111–116. 13 indexed citations
9.
Dugan, Michael C. & Fazlul H. Sarkar. (1998). Current Concepts in Pancreatic Cancer. Pancreas. 17(4). 325–333. 13 indexed citations
10.
Dergham, Sanaa T., et al.. (1998). Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy. Journal of Hepato-Biliary-Pancreatic Surgery. 5(3). 269–272. 15 indexed citations
11.
Mohammad, Ramzi M., Michael C. Dugan, Sanaa T. Dergham, et al.. (1998). Establishment of a Human Pancreatic Tumor Xenograft Model. Pancreas. 16(1). 19–25. 33 indexed citations
12.
Dergham, Sanaa T., Yong Q. Chen, Michael C. Dugan, et al.. (1998). Inhibition of Pancreatic Tumor Cell Growth in Culture by p21WEF1 Recombinant Adenovirus. Pancreas. 16(2). 107–113. 39 indexed citations
13.
Dergham, Sanaa T., Michael C. Dugan, Yong Q. Chen, et al.. (1997). The clinical significance of p21WAF1/CIP-1 and p53 expression in pancreatic adenocarcinoma. Cancer. 80(3). 372–381. 52 indexed citations
14.
Shridhar, Viji, Xiaohong Wang, Ravi Shridhar, et al.. (1997). Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer. Oncogene. 14(18). 2213–2216. 14 indexed citations
15.
Dergham, Sanaa T., Michael C. Dugan, Wei Du, et al.. (1997). Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma. International Journal of Pancreatology. 21(2). 127–143. 71 indexed citations
16.
Dugan, Michael C., Sanaa T. Dergham, Laura Biernat, et al.. (1997). HER-2/neu Expression in Pancreatic Adenocarcinoma. Pancreas. 14(3). 229–236. 64 indexed citations
17.
Dugan, Michael C., et al.. (1997). Phialophora verrucosa infection in a BMT patient. Bone Marrow Transplantation. 20(9). 789–791. 26 indexed citations
18.
Savaşan, Süreyya, et al.. (1996). Acute myeloid leukaemia with t(8;16)(p11;p13) in a child after intrauterine X‐ray exposure. British Journal of Haematology. 94(4). 702–704. 8 indexed citations
19.
Dugan, Michael C.. (1996). Primary adrenal leiomyosarcoma in acquired immunodeficiency syndrome.. PubMed. 120(9). 797–8. 4 indexed citations
20.
Shridhar, Ravi, Viji Shridhar, Xiaohong Wang, et al.. (1996). Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors.. PubMed. 56(19). 4347–50. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aeree Kim Breakdown of academic impact, for papers by Paul G. O’Reilly Breakdown of academic impact, for papers by Raphael Pelossof Breakdown of academic impact, for papers by Fredrik Erlandsson Breakdown of academic impact, for papers by Yuze Wu Breakdown of academic impact, for papers by Tsutomu Iwasa Breakdown of academic impact, for papers by Xin Song Breakdown of academic impact, for papers by Omar Khan Breakdown of academic impact, for papers by Dapeng Hao Breakdown of academic impact, for papers by Vidya Kamath
Rankless by CCL
2026